Breast cancer drug 'a life-saver'

June 06, 2006

From BBC Health - June 05, 2006 08:54

Use of a new class of breast cancer drug has the potential to save 1,000 lives a year in the UK, trials suggest.

Read More

Use of a new class of breast cancer drug has the potential to save 1,000 lives a year in the UK, trials suggest.

Aromasin cut the risk of death among postmenopausal women with hormone-sensitive primary breast cancer by 17% compared with standard therapy.

We repair MRI Coils, RF amplifiers, Gradient Amplifiers and Injectors.

MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013

Instead of five years of the drug tamoxifen, the women were switched to Aromasin after two to three years.

Details of the UK-led study were presented to an American Society of Clinical Oncology conference.